本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

28.17
+0.60002.18%
盤後27.16-1.0100-3.59%19:30 EDT
成交量:192.00萬
成交額:5,421.37萬
市值:35.58億
市盈率:-15.44
高:28.60
開:27.54
低:27.14
收:27.57
52周最高:41.94
52周最低:16.10
股本:1.26億
流通股本:7,811.99萬
量比:1.29
換手率:2.46%
股息:- -
股息率:- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
淨資產收益率:-108.49%
總資產收益率:-13.77%
市淨率:22.76
市盈率(LYR):-17.64

資料載入中...

2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities